Market closed

Merck & Co./$MRK

14:30

16:10

17:45

19:25

21:00

1D1W1MYTD1Y5YMAX

About Merck & Co.

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Ticker

$MRK

Sector

Health Care

Trading on

NYSE

Industry

Pharmaceuticals

Headquarters

Rahway, United States

Employees

71,000

Website

www.merck.com

Merck & Co. Metrics

BasicAdvanced

$255B

21.13 $4.78

0.40 $3.12

3.21%

Price and volume

Market cap

$255B

Beta

0.4

52-week high

$134.63

52-week low

$94.48

Average daily volume

11M

Dividend rate

$3.12

Financial strength

Current ratio

1.364

Quick ratio

0.917

Long term debt to equity

78.505

Total debt to equity

85.572

Dividend payout ratio (TTM)

63.72%

Interest coverage (TTM)

15.08%

Management effectiveness

Return on assets (TTM)

10.53%

Return on equity (TTM)

28.33%

Valuation

Price to earnings (TTM)

21.127

Price to revenue (TTM)

4.048

Price to book

5.75

Price to tangible book (TTM)

44.12

Price to free cash flow (TTM)

17.243

Dividend yield (TTM)

3.09%

Forward dividend yield

3.21%

Growth

Revenue change (TTM)

6.51%

Earnings per share change (TTM)

165.47%

3-year revenue growth (CAGR)

11.05%

3-year earnings per share growth (CAGR)

19.00%

3-year dividend per share growth (CAGR)

5.90%

What the Analysts think about Merck & Co.

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Merck & Co. stock.

Merck & Co. Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

Merck & Co. Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

Merck & Co. News

AllArticlesVideos

We've seen patients on transplant lists taken off of them after starting Winrevair, says Merck CEO

CNBC Television·4 hours ago

Merck CEO Robert Davis goes one-on-one with Jim Cramer

CNBC Television·4 hours ago

The Big 3: PEP, AVAV, MRK

Schwab Network·12 hours ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $MRK

$

Capital at risk

Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Merck & Co. stock?

Merck & Co. (MRK) has a market cap of $255B as of January 15, 2025.

What is the P/E ratio for Merck & Co. stock?

The price to earnings (P/E) ratio for Merck & Co. (MRK) stock is 21.13 as of January 15, 2025.

Does Merck & Co. stock pay dividends?

Yes, the Merck & Co. (MRK) stock pays dividends to shareholders. As of January 15, 2025, the dividend rate is $3.12 and the yield is 3.21%. Merck & Co. has a payout ratio of 63.72% on a trailing twelve-month basis.

When is the next Merck & Co. dividend payment date?

The next Merck & Co. (MRK) dividend payment date is unconfirmed.

What is the beta indicator for Merck & Co.?

Merck & Co. (MRK) has a beta rating of 0.4. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.